Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -290.08x is in line with its 4-year average of -297.79x, near the high end of its 4-year range (-891.47x–-43.87x).
36.48% above its 12-month average of -456.66x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-07-31): -410.83x.
INTEREST COVERAGE RATIO
-290.08x
INTEREST COVERAGE RATIO AVG TTM
-456.66x
INTEREST COVERAGE RATIO AVG 3Y
-315.47x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+36.48%
CURRENT VS 3Y AVG
+8.05%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 457 covered companies
CURRENT VS SECTOR MEDIAN
-5043.26%
vs the sector median at left
Clearmind Medicine Inc.
Market Cap
$1.06M
Interest Coverage Ratio
-290.08x
TTM Avg
-456.66x
3Y Avg
-315.47x
5Y Avg
N/A
Market Cap
$1.04M
Interest Coverage Ratio
-2.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10M
Interest Coverage Ratio
-7.46x
TTM Avg
10.39x
3Y Avg
21.90x
5Y Avg
21.90x
Market Cap
$1.15M
Interest Coverage Ratio
-4.20x
TTM Avg
1.01x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$1.21M
Interest Coverage Ratio
-42.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.26M
Interest Coverage Ratio
-134.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$869976.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
Market Cap
$859931.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$858810.00
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clearmind Medicine Inc. (CMND) | $1.06M | -290.08x | -456.66x | -315.47x | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | -2.27x | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | -7.46x | 10.39x | 21.90x | 21.90x |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | -4.20x | 1.01x | 1.00x | 1.00x |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.21M | -42.24x | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.26M | -134.94x | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $869976.00 | N/A | 354.05x | 372.60x | 299.52x |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858810.00 | N/A | 1.00x | 1.00x | 1.00x |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | N/A | N/A | N/A | N/A |
Interest Coverage
-290.1x
Debt/Equity
0.14
Current Ratio
4.31
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-07-31 | -410.83x |
| 2026-04-30 | -371.18x |
| 2026-01-31 | -891.47x |
| 2025-07-31 | -153.15x |
| 2025-04-30 | -166.13x |
| 2025-01-31 | -171.68x |
| 2024-10-31 | -43.87x |
| 2022-10-31 | -350.36x |
| 2022-07-31 | -121.41x |
